SALIXIN A/S: Financial statements 2023
CVR: 33776748
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
SALIXIN A/S (CVR 33776748) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -285,596 and a net result of DKK -8,533,789 compared with DKK 54,927 the year before. Equity in the 2023 report amounted to DKK -1,033,489. The company had 1 employee in the financial year.
- Gross Profit
- DKK -285,596
- Profit/Loss
- DKK -8,533,789
- Equity
- DKK -1,033,489
- Total Assets
- DKK 2,003,798
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -286K | -8.5M | -1M | 1 |
| 2022 | - | 496K | 55K | 4M | 1 |
| 2021 | - | 9.1M | 6.3M | 3.9M | 2 |
| 2020 | - | 70K | -746K | -2.4M | 2 |
| 2019 | - | -5K | -889K | -1.7M | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 14, 2023, Andreas Ydesen has left the board of directors of SALIXIN A/S.
As of September 27, 2023, Michael Bundgaard has joined the board of directors of SALIXIN A/S.
As of September 27, 2023, Andreas Ydesen has joined the board of directors of SALIXIN A/S.
As of September 26, 2023, Michael Bundgaard has left the board of directors of SALIXIN A/S.
As of September 26, 2023, Andreas Ydesen has left the board of directors of SALIXIN A/S.
As of July 14, 2023, Henrik Lyngsø Bach has joined the board of directors of SALIXIN A/S.
As of July 14, 2023, Andreas Ydesen has joined the board of directors of SALIXIN A/S.
As of July 14, 2023, Henrik Lyngsø Bach is registered as director of SALIXIN A/S.
As of July 14, 2023, Andreas Ydesen has stepped down as director of SALIXIN A/S.
As of July 13, 2023, Henrik Lyngsø Bach has left the board of directors of SALIXIN A/S.
About SALIXIN A/S
SALIXIN A/S is a Danish company of the type Aktieselskab based in Tylstrup, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Allan Juul Bech. The board consists of Michael Bundgaard (chair), Allan Juul Bech and Louise Bech. The company is owned by Ny Vraa A/S. The company has 1 employee (2022). In 2025, the company reported a gross profit of DKK 169,447 and a net result of DKK 106,174 compared with DKK 1,051,659 the year before. Equity in the 2025 report amounted to DKK 124,343.